Last checked at 28 Mar 2022 07:30
Reach
28 March 2022
Microsaic Systems plc
("Microsaic" or the "Company")
Microsaic miniaturised technology in first UK deployment of COVID-19 sewage sentinel detection system
Microsaic Systems plc (AIM: MSYS), the developer of micro-engineering chip-based mass spectrometry equipment, is pleased to note the update by DeepVerge plc (AIM: DVRG) ("DeepVerge") provided today regarding the first UK deployment of their Microtox®PD pathogen detection system.
While there are no new orders for Microsaic at this stage, Microsaic and DeepVerge have continued to work closely together to develop further iterations of the Microtox®PD units and on potential upgrades to the existing Modern Water equipment in miniaturised form.
Gerry Brandon, Executive Chairman of Microsaic commented:
"These successful installations once again exemplify the close working partnership between DeepVerge and Microsaic, and our aligned approach to the application of miniaturised but powerful detection technologies in the environmental sector."
Enquiries: |
|
Microsaic Systems plc Gerry Brandon Chairman
| +44 (0)734 0055 648 |
Singer Capital Markets(Nominated Adviser & Joint Broker) | +44 (0)20 7496 3000 |
Aubrey Powell / Tom Salvesen / George Tzimas
|
|
Turner Pope Investments (TPI) Limited (Broker) Andy Thacker / James Pope | +44 (0) 20 3657 0050 |
|
|
About Microsaic
Microsaic develops and commercialises micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow, or in frontline environmental monitoring